John H. Rex
Directeur Technique/Scientifique/R&D chez F2G Ltd.
Profil
John H.
Rex is currently the Chief Medical Officer & Director at F2G Ltd.
He is also an Operating Partner at Advent Venture Partners LLP.
Previously, he served as the Vice Chairman at CLSI, Inc. and as the Head-Infection & Global Medicines Development at AstraZeneca GmbH from 2003 to 2016.
Dr. Rex completed his undergraduate degree at Rice University and obtained a doctorate from Baylor College of Medicine.
Postes actifs de John H. Rex
Sociétés | Poste | Début |
---|---|---|
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Directeur Technique/Scientifique/R&D | 02/11/2016 |
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Consultant / Advisor | 01/11/2015 |
Anciens postes connus de John H. Rex
Sociétés | Poste | Fin |
---|---|---|
AstraZeneca GmbH
AstraZeneca GmbH Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca GmbH is a German pharmaceutical company that manufactures and sells pharmaceutical drugs. The company is based in Wedel, Germany. The company was founded in 1999. The CEO is Hans Sijbesma. | Corporate Officer/Principal | 01/10/2016 |
CLSI, Inc.
CLSI, Inc. Information Technology ServicesTechnology Services CLSI, Inc. provides computer support services. CLSI was acquired by Infor Global Solutions (Canada) Ltd. from TBG, Inc. on December 10, 1992. | Directeur/Membre du Conseil | - |
Formation de John H. Rex
Rice University | Undergraduate Degree |
Baylor College of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 4 |
---|---|
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Finance |
CLSI, Inc.
CLSI, Inc. Information Technology ServicesTechnology Services CLSI, Inc. provides computer support services. CLSI was acquired by Infor Global Solutions (Canada) Ltd. from TBG, Inc. on December 10, 1992. | Technology Services |
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Health Technology |
AstraZeneca GmbH
AstraZeneca GmbH Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca GmbH is a German pharmaceutical company that manufactures and sells pharmaceutical drugs. The company is based in Wedel, Germany. The company was founded in 1999. The CEO is Hans Sijbesma. | Health Technology |